Start Willow vs bmiMD: Compare Prices, Shipping, and Compounds
Need a quick verdict on Start Willow vs bmiMD? Start Willow is built for patients who want direct-pay access to compounded semaglutide with a fast delivery promise and no insurance or membership requirements. bmiMD is focused on compounded tirzepatide with lower long-term monthly equivalents if you commit to multi-month plans and free subscription shipping.
Start Willow: See Semaglutide Pricing
How the two providers differ at a glance
The most distinctive differences between Start Willow and bmiMD are medication type and compounding status, pricing and billing options, shipping speed and commitments, clinician access and eligibility, and regulatory notes about compounded medications. The sections below compare these points directly using only the supplied evidence.
1. Medication type and compounding status
Start Willow offers a compounded semaglutide formulation described as “compounded semaglutide” and framed as a customized treatment option comparable to Ozempic and tirzepatide. bmiMD offers compounded tirzepatide described as Compounded GLP-1/GIP (Tirzepatide). Both vendors explicitly note that compounded medications are not FDA approved and are not reviewed by the FDA for safety, effectiveness, or quality.
2. Pricing structure and billing commitments
Start Willow lists pricing “From $249 per Month” with the FAQ stating $249 for the first month and $299/month ongoing, and it flags the ongoing $299 rate as on the higher end of the comparison list. bmiMD lists tirzepatide pricing by billing term: $179 month-to-month; $159/mo for three months; $149/mo for six months; $139/mo for a 12-month plan. bmiMD highlights that the lowest $139/month rate requires a 12-month commitment and that total prepaid charge should be confirmed.
Start Willow: Start Your Online Intake
3. Shipping speed, refills, and delivery commitments
Start Willow guarantees delivery in 3 days or less from its licensed pharmacy network and advertises same-day prescriptions and free 2-Day shipping when in stock. bmiMD advertises free subscription shipping on every order and online refills with delivery to your door. Start Willow emphasizes a rapid delivery window; bmiMD emphasizes free shipping as part of subscription plans.
4. Clinician review, eligibility, and access
Start Willow prescribes its compounded semaglutide “after an online clinician review” and presents its direct-pay, no-insurance model as an advantage for patients frustrated by insurance prior authorization. bmiMD offers 24/7 clinician access and notes that treatment is available only when a licensed clinician determines it is medically appropriate. bmiMD also calls for confirming eligibility, medication, total cost, renewal terms, and state availability before enrollment.
5. Regulatory and safety notes preserved from sources
Both sources include the regulatory note that compounded medications are not FDA approved and are not reviewed by the FDA for safety, effectiveness, or quality. Start Willow adds that compounded medications are prepared by state-licensed compounding pharmacies operating under state board oversight and required to meet USP compounding standards; bmiMD states medications are prepared in a state-licensed pharmacy and independently verified in FDA- and DEA-registered labs.
Comparison table
| Criteria | Start Willow | bmiMD |
|---|---|---|
| Medication offered | Compounded semaglutide | Compounded tirzepatide |
| Starting price | From $249 per Month; $249 first month, $299/mo ongoing | $179 month-to-month; $159/3-mo; $149/6-mo; $139/12-mo |
| Shipping | Delivery in 3 days or less; same-day prescriptions; free 2-Day shipping in stock | Free subscription shipping on every order; online refills and delivery |
| Clinician access and eligibility | Online clinician review; no insurance or membership required | 24/7 clinician access; treatment when licensed clinician approves; confirm eligibility |
| Regulatory note | Compounded medications are not FDA approved; prepared by state-licensed compounding pharmacies | Compounded medications are not FDA approved; prepared in state-licensed pharmacy and independently verified labs |
Practical verdict and who should pick which
Start Willow vs bmiMD comes down to priorities. Start Willow is a better fit for patients who want direct-pay access to compounded semaglutide, prefer to avoid insurance and membership processes, and value a guaranteed 3-day delivery window. bmiMD is a better fit for patients who want compounded tirzepatide and are looking to lower their monthly equivalent by choosing longer prepaid plans and free subscription shipping.
bmiMD: Check Multi-Month Savings
Start Willow: Begin Online Clinician Review
Choose Start Willow if…
You prioritize a direct-pay model that requires no insurance or membership fees, need compounded semaglutide, and want a provider that guarantees delivery in 3 days or less and offers same-day prescriptions when in stock. Note that Start Willow lists $249 for the first month and $299/month ongoing and uses compounded formulations that are not FDA approved.
Choose bmiMD if…
You prefer compounded tirzepatide and want lower long-term monthly equivalents by committing to multi-month plans with free subscription shipping. Be aware the lowest $139/month rate requires a 12-month commitment and that compounded medications are not FDA approved.
Start Willow vs bmiMD is primarily a choice between semaglutide with fast direct-pay delivery and tirzepatide with multi-month pricing options. If a detail is not supplied here, it was not included in the captured evidence.